Browsing Tag
Memo Therapeutics AG
1 post
Ipsen agrees €700m Memo Therapeutics deal as acquisition spree accelerates
Ipsen agrees a €700 million Memo Therapeutics deal days after Kartos. Read how the acquisitions reshape its rare-disease pipeline and cash strategy now.